LIPOCINE INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
LIPOCINE INC. (LPCN) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $58.15 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-04
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $58.15K, a 10.83% decline year-over-year.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $65.40K, a 7.89% decline year-over-year.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-12-31 was $53.03K, a 46.48% decline year-over-year.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $53.26K, a 50.64% decline year-over-year.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $242.50K, a 40.64% decline from fiscal 2024.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $408.55K, a 37.57% decline from fiscal 2023.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $654.44K, a 2.88% increase from fiscal 2022.
- LIPOCINE INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $636.14K, a 5.33% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $58.15K 10-Q · filed 2026-08-04 | $123.54K 10-Q · filed 2026-08-04 | $176.58K derived: sum of 3 quarters · filed 2026-08-04 | $229.83K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $65.40K 10-Q · filed 2026-05-07 | $118.43K derived: sum of 2 quarters · filed 2026-05-07 | $171.69K derived: sum of 3 quarters · filed 2026-05-07 | $236.89K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $53.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $106.29K derived: sum of 2 quarters · filed 2026-03-10 | $171.50K derived: sum of 3 quarters · filed 2026-08-04 | $242.50K 10-K · filed 2026-03-10 |
| 2025-09-30 | $53.26K 10-Q · filed 2025-11-06 | $118.46K derived: sum of 2 quarters · filed 2026-08-04 | $189.46K 10-Q · filed 2025-11-06 | $288.55K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $65.20K 10-Q · filed 2026-08-04 | $136.21K 10-Q · filed 2026-08-04 | $235.29K derived: sum of 3 quarters · filed 2026-08-04 | $343.19K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $71.00K 10-Q · filed 2026-05-07 | $170.09K derived: sum of 2 quarters · filed 2026-05-07 | $277.98K derived: sum of 3 quarters · filed 2026-05-07 | $380.25K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $99.09K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $206.98K derived: sum of 2 quarters · filed 2026-03-10 | $309.25K derived: sum of 3 quarters · filed 2026-03-10 | $408.55K 10-K · filed 2026-03-10 |
| 2024-09-30 | $107.89K 10-Q · filed 2025-11-06 | $210.16K derived: sum of 2 quarters · filed 2025-11-06 | $309.46K 10-Q · filed 2025-11-06 | $463.18K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $102.27K 10-Q · filed 2025-08-05 | $201.57K 10-Q · filed 2025-08-05 | $355.28K derived: sum of 3 quarters · filed 2025-08-05 | $513.37K derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $99.31K 10-Q · filed 2025-05-08 | $253.02K derived: sum of 2 quarters · filed 2025-05-08 | $411.11K derived: sum of 3 quarters · filed 2025-05-08 | $575.97K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $153.71K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $311.80K derived: sum of 2 quarters · filed 2025-03-13 | $476.67K derived: sum of 3 quarters · filed 2025-03-13 | $654.44K 10-K · filed 2025-03-13 |
| 2023-09-30 | $158.09K 10-Q · filed 2024-11-07 | $322.95K derived: sum of 2 quarters · filed 2024-11-07 | $500.73K 10-Q · filed 2024-11-07 | $666.04K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $164.87K 10-Q · filed 2024-08-08 | $342.64K 10-Q · filed 2024-08-08 | $507.95K derived: sum of 3 quarters · filed 2024-08-08 | $668.18K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $177.77K 10-Q · filed 2024-05-09 | $343.09K derived: sum of 2 quarters · filed 2024-05-09 | $503.31K derived: sum of 3 quarters · filed 2024-05-09 | $642.88K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $165.32K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $325.54K derived: sum of 2 quarters · filed 2024-03-07 | $465.11K derived: sum of 3 quarters · filed 2024-03-07 | $636.14K 10-K · filed 2024-03-07 |
| 2022-09-30 | $160.23K 10-Q · filed 2023-11-08 | $299.80K derived: sum of 2 quarters · filed 2023-11-08 | $470.82K 10-Q · filed 2023-11-08 | $625.46K derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $139.57K 10-Q · filed 2023-08-10 | $310.60K 10-Q · filed 2023-08-10 | $465.23K derived: sum of 3 quarters · filed 2023-08-10 | $620.23K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $171.03K 10-Q · filed 2023-05-11 | $325.66K derived: sum of 2 quarters · filed 2023-05-11 | $480.66K derived: sum of 3 quarters · filed 2023-05-11 | $627.41K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $154.63K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $309.63K derived: sum of 2 quarters · filed 2023-03-10 | $456.38K derived: sum of 3 quarters · filed 2023-03-10 | $603.95K 10-K · filed 2023-03-10 |
| 2021-09-30 | $155.00K 10-Q · filed 2022-11-09 | $301.75K derived: sum of 2 quarters · filed 2022-11-09 | $449.31K 10-Q · filed 2022-11-09 | $683.90K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $146.75K 10-Q · filed 2022-08-08 | $294.31K 10-Q · filed 2022-08-08 | $528.90K derived: sum of 3 quarters · filed 2022-08-08 | $880.52K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $147.57K 10-Q · filed 2022-05-09 | $382.15K derived: sum of 2 quarters · filed 2022-05-09 | $733.78K derived: sum of 3 quarters · filed 2022-05-09 | $1.20M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $234.59K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-09 | $586.21K derived: sum of 2 quarters · filed 2022-03-09 | $1.05M derived: sum of 3 quarters · filed 2022-03-09 | $1.37M 10-K · filed 2022-03-09 |
| 2020-09-30 | $351.62K 10-Q · filed 2021-11-10 | $816.68K derived: sum of 2 quarters · filed 2021-11-10 | $1.14M 10-Q · filed 2021-11-10 | $1.39M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $465.06K 10-Q · filed 2021-08-05 | $786.97K 10-Q · filed 2021-08-05 | $1.04M derived: sum of 3 quarters · filed 2021-08-05 | $1.10M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $321.91K 10-Q · filed 2021-05-06 | $576.36K derived: sum of 2 quarters · filed 2021-05-06 | $634.47K derived: sum of 3 quarters · filed 2021-05-06 | $1.08M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $254.44K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $312.56K derived: sum of 2 quarters · filed 2021-03-11 | $758.91K derived: sum of 3 quarters · filed 2021-03-11 | $1.04M 10-K · filed 2021-03-11 |
| 2019-09-30 | $58.11K 10-Q · filed 2020-11-10 | $504.46K derived: sum of 2 quarters · filed 2020-11-10 | $781.39K 10-Q · filed 2020-11-10 | $1.11M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $446.35K 10-Q · filed 2020-08-06 | $723.28K 10-Q · filed 2020-08-06 | $1.06M derived: sum of 3 quarters · filed 2020-08-06 | $1.30M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $276.93K 10-Q · filed 2020-05-07 | $609.68K derived: sum of 2 quarters · filed 2020-05-07 | $853.21K derived: sum of 3 quarters · filed 2020-05-07 | $1.31M derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $332.75K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $576.29K derived: sum of 2 quarters · filed 2020-03-13 | $1.03M derived: sum of 3 quarters · filed 2020-03-13 | $1.46M 10-K · filed 2020-03-13 |
| 2018-09-30 | $243.54K 10-Q · filed 2019-11-12 | $697.69K derived: sum of 2 quarters · filed 2019-11-12 | $1.12M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $454.15K 10-Q · filed 2019-08-07 | $881.43K 10-Q · filed 2019-08-07 | ||
| 2018-03-31 | $427.28K 10-Q · filed 2019-05-08 | |||
| 2017-12-31 | $2.72M 10-K · filed 2019-03-06 | |||
| 2016-12-31 | $2.37M 10-K · filed 2019-03-06 | |||
| 2015-12-31 | $1.15M 10-K · filed 2018-03-12 | |||
| 2014-12-31 | $1.89M 10-K · filed 2017-03-06 | |||
| 2013-12-31 | $979.15K 10-K · filed 2015-03-11 | |||
| 2012-12-31 | $127.49K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |